Purchases and Sales Made in Q4 2024 in Fulcrum Therapeutics, Inc. (FULC)
This table provides information about the institutional ownership of Fulcrum Therapeutics, Inc. (FULC) during Q4 2024. The information is specifically focused on institutions that hold shares of Fulcrum Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 24, 2025
Q4 2024
|
Matisse Capital
|
BUY
|
- |
21.7K+ 20.36% |
$64.5K - $105K
|
128K
$543K
|
|
|
Jan 15, 2025
Q4 2024
|
Skopos Labs, Inc.
Riverhead, NY |
BUY
|
- |
3.94KNew |
$11.7K - $19.1K
|
3.94K
$16.6K
|
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
BUY
|
- |
328+ 24.5% |
$974 - $1.59K
|
1.67K
$7.05K
|
|
|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
SELL
|
- |
-2.58K- 7.8% |
$7.65K - $12.5K
|
30.4K
$129K
|